175 related articles for article (PubMed ID: 35738329)
1. Exhaustion of CD39-Expressing CD8
Globig AM; Mayer LS; Heeg M; Andrieux G; Ku M; Otto-Mora P; Hipp AV; Zoldan K; Pattekar A; Rana N; Schell C; Boerries M; Hofmann M; Neumann-Haefelin C; Kuellmer A; Schmidt A; Boettler T; Tomov V; Thimme R; Hasselblatt P; Bengsch B
Gastroenterology; 2022 Oct; 163(4):965-981.e31. PubMed ID: 35738329
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunction.
Marius W; Leticia OF; Friedrich KN; Stephan M; Louisa H; Tabea S; Elisa S; Pauline W; Yi D; Qi M; Barbara S; Carsten B; Walter F; Jasmin W; Franziska B
Oncoimmunology; 2024; 13(1):2346359. PubMed ID: 38737794
[TBL] [Abstract][Full Text] [Related]
3. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
4. CD39 Expression Identifies Terminally Exhausted CD8+ T Cells.
Gupta PK; Godec J; Wolski D; Adland E; Yates K; Pauken KE; Cosgrove C; Ledderose C; Junger WG; Robson SC; Wherry EJ; Alter G; Goulder PJ; Klenerman P; Sharpe AH; Lauer GM; Haining WN
PLoS Pathog; 2015 Oct; 11(10):e1005177. PubMed ID: 26485519
[TBL] [Abstract][Full Text] [Related]
5. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract][Full Text] [Related]
6. 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39
Leem G; Park J; Jeon M; Kim ES; Kim SW; Lee YJ; Choi SJ; Choi B; Park S; Ju YS; Jung I; Kim S; Shin EC; Lee JY; Park SH
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335029
[TBL] [Abstract][Full Text] [Related]
7. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients.
Shahbazi M; Moulana Z; Sepidarkish M; Bagherzadeh M; Rezanejad M; Mirzakhani M; Jafari M; Mohammadnia-Afrouzi M
Microb Pathog; 2021 Apr; 153():104779. PubMed ID: 33548481
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Molecules PD-1, CD73 and CD39 Are Expressed by CD8
Smith CJ; Snyder CM
Front Immunol; 2021; 12():704862. PubMed ID: 34335618
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CD39 and Exogenous APT102 Correct Immune Dysfunction in Experimental Colitis and Crohn's Disease.
Robles RJ; Mukherjee S; Vuerich M; Xie A; Harshe R; Cowan PJ; Csizmadia E; Wu Y; Moss AC; Chen R; Robson SC; Longhi MS
J Crohns Colitis; 2020 Jul; 14(6):818-830. PubMed ID: 31693091
[TBL] [Abstract][Full Text] [Related]
10. NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine.
Bai A; Moss A; Rothweiler S; Serena Longhi M; Wu Y; Junger WG; Robson SC
Nat Commun; 2015 Nov; 6():8819. PubMed ID: 26549640
[TBL] [Abstract][Full Text] [Related]
11. Endogenous antisense RNA curbs CD39 expression in Crohn's disease.
Harshe RP; Xie A; Vuerich M; Frank LA; Gromova B; Zhang H; Robles RJ; Mukherjee S; Csizmadia E; Kokkotou E; Cheifetz AS; Moss AC; Kota SK; Robson SC; Longhi MS
Nat Commun; 2020 Nov; 11(1):5894. PubMed ID: 33208731
[TBL] [Abstract][Full Text] [Related]
12. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells.
Balança CC; Salvioni A; Scarlata CM; Michelas M; Martinez-Gomez C; Gomez-Roca C; Sarradin V; Tosolini M; Valle C; Pont F; Ferron G; Gladieff L; Vergez S; Dupret-Bories A; Mery E; Rochaix P; Fournié JJ; Delord JP; Devaud C; Martinez A; Ayyoub M
JCI Insight; 2021 Jan; 6(2):. PubMed ID: 33332284
[TBL] [Abstract][Full Text] [Related]
13. Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
Gibson DJ; Elliott L; McDermott E; Tosetto M; Keegan D; Byrne K; Martin ST; Rispens T; Cullen G; Mulcahy HE; Cheifetz AS; Moss AC; Robson SC; Doherty GA; Ryan EJ
Inflamm Bowel Dis; 2015 Dec; 21(12):2806-14. PubMed ID: 26332314
[TBL] [Abstract][Full Text] [Related]
14. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer.
Zahran AM; Rayan A; Zahran ZAM; Mohamed WMY; Mohamed DO; Abdel-Rahim MH; El-Badawy O
PLoS One; 2022; 17(1):e0262650. PubMed ID: 35051220
[TBL] [Abstract][Full Text] [Related]
16. The CD39
Zou F; Tan J; Liu T; Liu B; Tang Y; Zhang H; Li J
Mol Ther; 2021 May; 29(5):1794-1807. PubMed ID: 33484968
[TBL] [Abstract][Full Text] [Related]
17. CD39 Expression Defines Cell Exhaustion in Tumor-Infiltrating CD8
Canale FP; Ramello MC; Núñez N; Araujo Furlan CL; Bossio SN; Gorosito Serrán M; Tosello Boari J; Del Castillo A; Ledesma M; Sedlik C; Piaggio E; Gruppi A; Acosta Rodríguez EA; Montes CL
Cancer Res; 2018 Jan; 78(1):115-128. PubMed ID: 29066514
[TBL] [Abstract][Full Text] [Related]
18. Immune profiling identifies CD8
Chen Z; Guo ML; Li YY; Yan K; Li L; Shen F; Guan H; Liu QZ; Xu B; Lian ZX
Front Immunol; 2022; 13():894919. PubMed ID: 36420264
[TBL] [Abstract][Full Text] [Related]
19. Crossover Subsets of CD4
Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S
Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508
[TBL] [Abstract][Full Text] [Related]
20. High-dimensional profiling reveals Tc17 cell enrichment in active Crohn's disease and identifies a potentially targetable signature.
Globig AM; Hipp AV; Otto-Mora P; Heeg M; Mayer LS; Ehl S; Schwacha H; Bewtra M; Tomov V; Thimme R; Hasselblatt P; Bengsch B
Nat Commun; 2022 Jun; 13(1):3688. PubMed ID: 35760777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
